| Literature DB >> 24790671 |
Mihaela Tevet1, Cornel Dragan1, Carmen Saguna1, Doina Barbu1, Anca Roxana Lupu1.
Abstract
ABSTRACT: Secondary acute lymphoblastic leukaemia (sALL), defined as acute lymphoblastic leukaemia following another malignancy, irrespective of previous treatment, is a rare disease, and its biological characteristics have not been accurately described. We report the case of a 24-year old patient followed for Hodgkin's lymphoma at our clinic, who develops and is diagnosed, less than a year after obtaining complete remission, as having pro-B acute lymphoblastic leukaemia This case has been a real diagnostic and treatment challenge, as sALL following another haematological malignancy is quite rare.Entities:
Keywords: 11q23 mutation; Hodgkin's lymphoma; alkilating agents; immunophenotyping; prognostic factors; secondary acute leukaemia
Year: 2013 PMID: 24790671 PMCID: PMC3968475
Source DB: PubMed Journal: Maedica (Buchar) ISSN: 1841-9038